Pacific Bio (PACB) Tops Q3 EPS by 1c

Pacific Bio (NASDAQ: PACB) reported Q3 EPS of ($0.19), $0.01 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $23.5 million versus the consensus estimate of $28.55 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
• KT&G approves KRW 360 billion share buyback and retirement plan
• Amrize Ltd (AMRZ) PT Lowered to $42 at UBS on Lower Earnings Estimates